News & Updates

Maintenance monotherapy with olaparib appears safe and effective in Asian patients with platinum-sensitive relapsed (PSR) ovarian cancer, regardless of their BRCA status, as shown in the results of the phase III, open-label, single-arm L-MOCA study.

Long-term overall survival (OS) in patients with metastatic breast cancer (MBC) may be influenced by diabetes status, according to a retrospective study presented at ENDO 2022.

Vaginal antisepsis with chlorhexidine proves noninferior to that with iodine in terms of the incidence of gynaecologic surgery-associated urinary tract infection and vaginal irritation, as reported in a study.

Adherence to a healthy plant-based diet was tied to a reduced risk of breast cancer, according to a French study presented at Nutrition 2022. In contrast, an unhealthy plant-based diet may be tied to increased breast cancer risk.

Experiencing sexual assault, sexual harassment at work, or both appear to increase a woman’s risk of developing hypertension over a long-term period, according to an analysis of the Nurses’ Health Study II.

In terms of patient-reported success, the newer, adjustable, anchored single-incision mini-slings (SIMS) were noninferior to the synthetic, tension-free, standard mid-urethral slings (SMUS) for the surgical management of stress urinary incontinence (SUI) in women, the SIMS study suggests.

Use of niraparib in the maintenance setting appears to minimize the risk of progression in advanced ovarian cancer patients, with surgical timing having little to no effect on the drug’s efficacy, as shown in a post hoc analysis of the phase III PRIMA/ENGOT-OV26/GOG-3012 study.